转移性肺癌抗体治疗患者的突发性耳聋与前庭病变
本文报告一例转移性支气管癌患者在免疫检查点治疗期间出现突发眩晕和双侧耳聋的病例。听力学、前庭功能检查、头颅磁共振成像(cMRI)及腰椎穿刺证实双侧感音神经性耳聋和前庭功能丧失,影像显示前庭耳蜗神经强化。初期怀疑PD-L1抗体阿替利珠单抗所致,但进一步检查支持肿瘤脑膜病的诊断。
要点
- 转移性肺癌患者接受免疫检查点治疗期间出现突发眩晕和双侧耳聋需全面听力学与前庭功能评估。
- 头颅磁共振成像显示前庭耳蜗神经强化,腰椎穿刺有助于鉴别肿瘤脑膜病。
- 铂类化疗、检查点抑制剂治疗及转移性疾病背景下出现听力损失和前庭病变的鉴别诊断应纳入考虑。
核心结论
- 在铂类化疗、检查点抑制剂治疗和转移性疾病背景下出现听力损失和前庭病变时,应牢记相关鉴别诊断以进行适当的检查与治疗。
研究设计与样本
- 个案报道,描述一例转移性支气管癌患者在免疫检查点治疗期间出现突发眩晕和双侧耳聋的病例。
主要发现
- 听力学评估和前庭功能检查证实双侧感音神经性耳聋和双侧前庭功能丧失。
- 头颅磁共振成像显示前庭耳蜗神经强化。
- 初期怀疑PD-L1抗体阿替利珠单抗为症状原因,但进一步检查支持肿瘤脑膜病的怀疑。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
We describe the case of a patient who presented with sudden onset vertigo and bilateral deafness while under immune checkpoint therapy for metastatic bronchial carcinoma. Extensive audiologic assessment and vestibular function testing, as well as cranial magnetic resonance imaging (cMRI) and lumbar puncture was performed. The diagnostic workup confirmed bilateral sensorineural deafness and bilateral loss of vestibular function, while imaging revealed enhancement of the vestibulocochlear nerve. Initially, immunotherapy with PD-L1 antibody atezolizumab was the assumed cause of the described symptoms. However, further findings strengthened the suspicion of meningeosis neoplastica. The differential diagnoses of hearing loss and vestibulopathy in the context of platin-based chemotherapy, checkpoint inhibitor therapy and metastatic disease should be kept in mind for appropriate workup and therapy. Laryngoscope, 134:4347-4350, 2024.
引用
- Trache MC, Köntopf J, Stölzel K, et al. Sudden Deafness and Vestibulopathy in a Patient with Antibody Treatment for Metastatic Lung Cancer. Laryngoscope. 2024. PMID: 38666623. doi:10.1002/lary.31459
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。